Anpac Bio-Medical Science Co. sell Lokrim
Start price
19.08.23
/
20%
€1.97
Target price
19.08.24
-
Performance (%)
-77.46%
End price
19.01.24
€0.44
Summary
This prediction ended on 19.01.24 with a price of €0.44. Lokrim correctly predicted massive losses of -77.46% for Anpac Bio-Medical Science Co.. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Anpac Bio-Medical Science Co. | - | - | - |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
According to Lokrim what are the pros and cons of Anpac Bio-Medical Science Co. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Lokrim for this prediction
In the thread AnPac Bio-Medical Science Co. Ltd. ADR diskutieren
Sell Anpac Bio-Medical Science Co.